COMMUNIQUÉS West-GlobeNewswire

Herz P1 Smart BPM Under Investigation: Clinical-Grade Blood Pressure Monitoring for Valuable At-Home Health Tracking Support
20/04/2026
A 2026 informational overview of Herz P1 Smart BPM FDA 510K clearance, wrist blood pressure monitor accuracy considerations, irregular heartbeat detection features, at-home cardiovascular tracking awareness, and key [...]
ViriFlow Claims Evaluated: The Prostate-Supporting Formula for Men That Actually Works in Viri Flow Drops Reviewed
20/04/2026
A 2026 informational overview of ViriFlow's hard water mineral theory, saw palmetto and iodine-rich seaweed blend research, proprietary blend dosing transparency, liquid dropper format considerations, prostate [...]
Lirum Therapeutics Announces Positive LX-101 Data Selected for Presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting
20/04/2026
New York, NY, April 20, 2026 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new LX- [...]
GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025)
20/04/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 20, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life- [...]
GENFIT : Publication du rapport de performance extra-financière 2026 (exercice 2025)
20/04/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 20 avril 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies [...]
First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives in Canada and Reduce Health System Costs Across G7 Countries
20/04/2026
42,000 Canadians are hospitalized with bloodstream infections each year. New findings show fast diagnostics could prevent 2,400 of those patients annually from progressing to sepsis and save $42M for the Canadian [...]
Une analyse médico-économique, la première du genre, montre que le recours précoce à des tests de diagnostic rapides pour soigner le sepsis pourrait sauver des milliers de vies au Canada et réduire les coûts du système de santé dans les pays du G7
20/04/2026
Chaque année, 42 000 Canadiens sont hospitalisés pour des infections sanguines. De nouvelles études montrent que des diagnostics rapides pourraient éviter que 2 400 de ces patients ne développent un sepsis chaque année [...]
ONWARD Medical Publishes Closing of Bookbuild Offering
20/04/2026
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, April 20, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. ( [...]
ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform
20/04/2026
VANCOUVER, British Columbia, April 20, 2026 (GLOBE NEWSWIRE) -- ViewsML , a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today [...]
BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform
20/04/2026
CE Mark under the European Union Medical Device Regulation (EU MDR) achieved for Virtuoso®, BVI’s first dual-function phaco-vitrectomy platform designed to deliver advanced control, efficiency, and versatility for both [...]
Baba Appoints Former Mount Sinai Executive Director to Lead Clinical Operations
20/04/2026
Platform taps decade+ of health system clinical leadership to scale virtual, longitudinal advocacy for Medicare, Medicare Advantage, and Medicaid populations NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Baba, an [...]
Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care
20/04/2026
NEW YORK and LEAMINGTON, Ontario, April 20, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of [...]
AVIS À IGNORER -- BVI Medical, Inc.
20/04/2026
WALTHAM, Mass., 20 avr. 2026 (GLOBE NEWSWIRE) -- BVI Medical, Inc. nous informe que les journalistes et autres lecteurs doivent ignorer le communiqué de presse publié le 20 avril 2026, « BVI annonce l’obtention du [...]
Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc.
20/04/2026
A Compliance-Focused AI and Web3 Financial Ecosystem Proposed Transaction Includes Joint Development Framework, Vystar Series B Consideration, and Strategic Alignment Around the R3EQ Ecosystem ■ ■ ■ Vystar to Receive [...]
First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases
20/04/2026
First Tracks Biotherapeutics launches with $180 million in cash and two-year cash-runway Trading of TRAX begins on Nasdaq today SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: [...]
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
20/04/2026
Validation study targets sub-3-minute results to capture global roadside testing market and significantly reduce analysis time from 10 minutes U.S. Roadside drug testing market projected to reach $1.62 billion by 2030 [...]
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations
20/04/2026
Focused on protecting and returning value of Jemperli and imsidolimab royalties to shareholders Launches with virtual model, including limited FTEs and minimal operating expenses, and approximately $140-$145 million in [...]
Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
20/04/2026
ORION CORPORATION PRESS RELEASE 20 APRIL 2026 at 16.00 EEST Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA Orion Corporation (Orion Pharma) today announced that its investigational [...]
Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026
20/04/2026
PALO ALTO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non [...]

Pages